Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ: BNTX )

114.13 +0.62 (+0.55%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 131,795
Open 112.80
Bid (Size) 104.65 (2)
Ask (Size) 118.00 (2)
Prev. Close 113.51
Today's Range 112.23 - 114.42
52wk Range 76.53 - 131.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS. 
Via Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool

Performance

YTD
+1.59%
+1.59%
1 Month
-5.49%
-5.49%
3 Month
-1.44%
-1.44%
6 Month
+38.31%
+38.31%
1 Year
+8.98%
+8.98%

More News

Read More
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
2 No-Brainer Stocks to Buy Before the End of 2024
Via The Motley Fool
Why Is BioNTech Stock Trading Higher On Friday?
Via Benzinga
The Analyst Landscape: 17 Takes On BioNTech
Via Benzinga
What Analysts Are Saying About BioNTech Stock
Via Benzinga
Breaking Down BioNTech: 16 Analysts Share Their Views
Via Benzinga
5 Top Stocks to Buy in December
Via The Motley Fool
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Via Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Via Benzinga
Exposures Product Safety
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
BioNTech Stock Got A IBD RS Rating Lift
Via Investor's Business Daily
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
Via Benzinga
BioNTech to Acquire Biotheus to Boost Oncology Strategy
From BioNTech SE
Via GlobeNewswire
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
Via Benzinga
This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Via Benzinga
Topics Government
Exposures Political
BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
Via Benzinga
Exposures COVID-19
BioNTech Jumps On Surprise Profit, Wide Sales Beat; But Lowers Outlook
Via Investor's Business Daily
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.